Skip to main content

Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.

Yang H, Ma Y, Chen G, Zhou H, Yamazaki T, Klein C, Pietrocola F, Vacchelli E, Souquere S, Sauvat A, Zitvogel L, Kepp O, Kroemer G
Oncoimmunology. 2016 Mar 10;5(6):e1149673. doi: 10.1080/2162402X.2016.1149673. eCollection 2016 Jun. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.

Antibodies from Article